In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

00:22 EDT 5th August 2015 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,100+

Wednesday 29th July 2015

Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy

PLEASANTON, Calif., July 30, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has submitted the cobas® EGFR Mutation Test v2 for Premarket Approval (PMA) to the U.S. Food and Drug Administration (FDA), as a companion diagnostic test for AZD9291, an AstraZeneca investigational therapy for non-small cell lung cancer patients with an acquired resistant mutation....

Point-of-care diagnostics for Ebola

Integrated DNA Technologies (IDT), USA, and Ubiquitome, New Zealand, have collaborated on the development of technology that can detect the Ebola virus in the field. The companies’ assay and PCR device will be used to detect Zaire ebolavirus, the species involved in the 2013–2015 West African Ebola outbreak. The goal of point-of-care diagnostic testing is to help stop disease transmission, es...

Fungal resistance a growing healthcare threat

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) is imploring global healthcare professionals and bodies to take a more active role in the growing problem of fungal resistance. The society believes that fungal infections are neglected worldwide, with over 300 million people of all ages suffering from a serious fungal infection every year. The ESCMID Fungal Infection S...

Pharmaceutical Research: In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383

Type: Original PaperPurposeTo assess accumulation and lysosomal sequestration of 9 drugs used in respiratory indications (plus imipramine as positive control) in the alveolar macrophage (AM) cell line NR8383.MethodsFor all drugs, uptake at 5 μM was...

HTG Molecular Diagnostics to Present at the Canaccord Genuity Growth Conference

TUCSON, Ariz., July 30, 2015 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management will be presenting at the Canaccord Genuity Growth Conference on Thursday, August 13, 2015 in Boston. HTG management is scheduled to present at 9:00 a.m. ET. A live audio webcast of the pr...

Escherichia coli-based detection of serum and urine markers for point-of-care diagnostics


Calcium channel; serotonin (5-HT) transporter (SLC6A4; SERT); estrogen receptor; androgen receptor

In vitro and mouse studies identified a

Factor IXa; Factor VIIIa

In vitro, rat, and mouse studies suggest inhibiting the Factor IXa-

Human cytomegalovirus (CMV) type 2 membrane protein (UL50); CMV type 3 membrane protein (UL53)

In vitro studies suggest disrupting UL50-

Boolean bactosensors for biomarker detection

Engineering bacteria to obey Boolean logic could provide a new tool for diagnostics.

Newly Appointed Acting CEO Outlines Immediate Plans for Novogen

SYDNEY, July 29, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: NVGN) today confirmed it is committed to progressing its ground-breaking technology platforms to Phase 1 clinical trials as soon as practicable and to ensure the Company delivers the best value for shareholders. Acting Chief Executive Officer, Iain Ross, said the Company currently had an...

World’s Top Female Surfers Compete for $125,000 Donation in Genetic Testing Vouchers to Clinics in the Battle for the Breasts

The sixteen participants have been announced for the second annual Battle for the Breasts hosted by Mauli Ola Foundation and presented by

Hologic Announces Financial Results for Third Quarter of Fiscal 2015

BEDFORD, Mass., July 29, 2015 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced today the Company's financial results for the fiscal third quarter ended June 27, 2015.  Quarterly revenues of $693.9 million increased 9.7% on a reported basis, and 12.2% on a constant currency basis.  GAAP earnings per share (EPS) of $0.10 increased 150%, while non-GAAP EPS of $0.43 increased 16.2...

Viamet to Present at Infectious Diseases Society for Obstetrics and Gynecology Annual Meeting

Phase 2a Data Demonstrate Advantages of Lead Agent VT-1161 over Current Antifungal Therapy Full Enrollment of Ongoing Phase 2b Trial in Recurrent Vulvovaginal Candidiasis Expected in Fourth Quarter of 2015 Viamet Pharmaceuticals, Inc. today announced that data from a Phase 2a study of VT-1161, the Company’s lead novel, oral antifungal...

Apogenix to Collaborate with R-Biopharm to Develop Immuno-Oncology Diagnostic Tests

Apogenix, a next generation immuno-oncology company, announced today that it has entered into an agreement with R-Biopharm, a global provider of innovative clinical diagnostics, to develop companion diagnostic tests for Apogenix' lead drug candidate APG101. APG101 is a CD95 ligand inhibitor which restores the body's immune response against tumors and inhibits invasive tumor cell growth. The drug c...

BIO Joins Coalition Cautioning Against Further Restructuring of Japan’s Pharmaceutical Pricing Structure

Today BIO joined a coalition of organizations urging the Government of Japan to maintain the established reimbursement pricing structure for pharmaceuticals and medical devices. While the Abe Administration continues to take impressive steps to promote the domestic and foreign innovative

SeraCare Life Sciences Unveils Rebranding Initiative to Support Company's Expanding Capabilities for Precision Diagnostics

MILFORD, Mass., July 29, 2015 /PRNewswire/ -- SeraCare Life Sciences, a leading partner to clinical laboratories and global in vitro diagnostics manufacturers, announced at the American Association of Clinical Chemistry (AACC) conference today, that it has launched its rebranding initiative as part of the company's expanding capabilities for the support of advanced diagnostics development. ...

HCW starts Semler Scientific at buy

H.C. Wainwright has launched coverage of Semler Scientific (NASDAQ:SMLR) with a “buy” rating and a 12-month price target of $8. The stock closed at $3.20 on Tuesday. Semler is a medical diagnostics company that is marketing a patented device for the risk assessment of peripheral arterial disease (PAD) and other vascular conditions. Known as FloChec, […]

Amarantus study of MSPrecise published in GENE

Data on Amarantus Diagnostics’ next generation sequencing molecular diagnostic test for multiple sclerosis, MSPrecise, has been published in the Elsevier journal, GENE. MSPrecise is a proprietary next-generation DNA sequencing assay for the identification of patients with relapsing-remitting multiple sclerosis (RRMS). A blood-based version of the test is in development. “Given the early mi...

Certara Launches Its Simcyp In Vitro (Data) Analysis Toolkit to Improve Drug Discovery and Development Study Results

This new standalone solution is designed to meet the needs of early-stage drug discovery and development researchers Certara®, the global biosimulation technology-enabled drug development company, today announced the launch of its Simcyp In Vitro (Data) Analysis (SIVA) Toolkit, version 1.0. The SIVA Toolkit is designed to enable the analysis...

Certara launches Simcyp In Vitro (Data) Analysis Toolkit

Certara, a Princeton, N.J.-based, global biosimulation technology-enabled drug development company, launched its Simcyp In Vitro (Data) Analysis (SIVA) Toolkit, version 1.0. The SIVA Toolkit is designed to enable the analysis of complex in vitro stud...

Cellular Research Introduces Whole Transcriptome Single Cell Precise Assays

Cellular Research, Inc., today announced an early access program for its new Whole Transcriptome Single Cell Precise™ Assays, which enable absolute and direct molecular counting of the entire transcriptome from single cells without any specialized equipment or training. “Recent technological advances have enabled the analysis of gene expressio...

CSSi LifeSciences™ and PRC Clinical Join Forces to Offer Extended Clinical Trial Services

GLEN BURNIE, Md., July 29, 2015 /PRNewswire/ -- CSSi LifeSciences™ formalized a strategic partnership agreement with PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences™ is specialized in strategic, marketing, and regulatory consulting, FDA advisory services, and patient recruitment services. The core expertise of PRC Clinical is focuse...

Ignyta Announces FDA Clearance of IND for RXDX-107

Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug application (IND) for Ignyta’s new chemical entity RXDX-107, a next-generation alkyl ester of bendamustine encapsulated in human serum albumin (HSA) to form nanoparticles. ...

Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening

WASHINGTON, July 29, 2015 /PRNewswire/ -- The Perinatal Quality Foundation (PQF) today announced a nationwide campaign to improve understanding of the advantages, limitations and clinically appropriate interpretation of results of noninvasive prenatal screening and other diagnostic tests for pregnant women and their healthcare providers. Quest Diagnostics (NYSE: DGX), the world's leading prov...


News Quicklinks